COVID-19 vaccine to be authorized in Europe 'within a week,' EU chief says
A COVID-19 vaccine will be authorized in the European Union "within a week," European Commission President Ursula von der Leyen announced Wednesday.
"Finally, within a week, the first vaccine will be authorized so that vaccinations can start immediately, and more will follow in the new year," von der Leyen said in an address to lawmakers at the European Parliament in Brussels. "In total, we have bought more than enough doses for everyone in Europe."

The EU's 27 member states will all be able to launch mass immunization programs on "the same day" that the vaccine is approved, according to von der Leyen.
"To get to the end of the pandemic, we will need up to 70% of the population vaccinated," she said. "This is a huge task, a big task. So let's start as soon as possible with the vaccination together, as 27, with a start at the same day."
The European Medicines Agency, the drug regulator for the European Union, announced Tuesday that a special meeting to discuss conditional authorization for a COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech will be moved up to Dec. 21. The meeting was originally scheduled for Dec. 29. The move comes amid mounting pressure on the agency after the United States and the United Kingdom both granted emergency-use authorization of the Pfizer/BioNTech vaccine and began immunization campaigns.
ABC News' Aicha El Hammar Castano and Ibtissem Guenfoud contributed to this report.






